HLX43 drug page Clinical trials

Trials with HLX43

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
3Countries
367Planned patients

Showing 1–1 of 1

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors
Recruiting Phase 1 367 patients NCT06115642

This study is an open-label first-in-human phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX43 in patients with advanced/metastatic solid tumors.

United States, China, Japan Nov 2023 – Nov 2027 Interventional
Combined with: HLX10

Where the recruiting trials are